ArticleEuropean journal of heart failure2025

Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis.

Lucia Venneri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.